Clinical trials
Terminated Observational Obesity trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
64 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 7 |
| 2008 | 6 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 5 |
| 2012 | 3 |
| 2013 | 6 |
| 2014 | 1 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 64 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 3 |
| Apollo Endosurgery, Inc. | 2 |
| Boston Scientific Corporation | 2 |
| Ethicon Endo-Surgery | 2 |
| Ohio State University | 2 |
| Oregon Health and Science University | 2 |
| Pennington Biomedical Research Center | 2 |
| Rockefeller University | 2 |
| The Cleveland Clinic | 2 |
| University Hospital, Lille | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 64 |
| Insulin Resistance | 8 |
| Diabetes Mellitus | 5 |
| Obesity, Morbid | 5 |
| Overweight | 5 |
| Weight Loss | 5 |
| Diabetes Mellitus, Type 2 | 4 |
| Atherosclerosis | 3 |
| Cardiovascular Diseases | 3 |
| Inflammation | 3 |
Trials
Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.